Lochmüller Lab seeking PhD student

The Lochmüller Research Group are seeking a highly motivated PhD student to join our team at the Childrens Hospital of Eastern Ontario Research Institute (CHEO RI). The project, part of the recently funded Brain-Heart Initiative at uOttawa, will involve working with advanced cell models to perform drug screens, biomarker studies, and mechanistic investigations into Myotonic Dystrophy Type 1 (DM1). Candidates with previous laboratory experience, particularly in cell culture and molecular biology are particularly encouraged to apply.

Check out the full description of the PhD opportunity.

Research Environment

The Lochmüller Research Group specializes in conducting scientific, genetic, and clinical investigations into neuromuscular disorders, while also providing clinical support for individuals affected by these conditions. Our primary objective is to unravel the reasons behind genetic variations in the human genome give rise to these often debilitating, and occasionally life-threatening disorders that impact the muscles and nervous system. Employing a translational approach from laboratory research to practical applications, we identify genetic defects in patients through in-depth phenotyping and next-generation sequencing. Subsequently, we delve into understanding molecular pathways using cell and animal models before progressing to preclinical and clinical trials testing innovative targeted therapies. The CHEO Research Institute is located in Ottawa, sharing a campus with the University of Ottawa, The Ottawa Hospital Research Institute, and the CHEO hospital. This arrangement fosters valuable collaboration among various groups, facilitating the exchange of resources and equipment. Ottawa provides a vibrant, inclusive, cost-effective, and friendly atmosphere for both academic pursuits and daily life. Additionally, the city benefits from excellent transportation links, both internally and to other Canadian cities.

Entry Requirements

Candidates are expected to hold or be about to obtain a MSc degree in a related subject/area. In addition, to selection by the Lochmüller Research group, candidates will need to apply to The University of Ottawa CMM program and fulfil their entry requirements.

How to Apply

If you are interested, please send you CV, Transcripts, and cover letter explaining why you are interested in this opportunity to Dr Sally Spendiff at . Applications should be submitted by the 8th of March. 

 

Copy of Lochmuller Lab - PhD opportunity (LLab)

Read next...

researcher of the year 2025

Dr. Hanns Lochmüller Awarded “Clinical Researcher of the Year” by University of Ottawa Faculty of Medicine

We are thrilled to announce that Dr. Hanns Lochmüller has been awarded the Clinical Researcher of the Year Award by the University of Ottawa Faculty...
Holland study

New Publication: Galactose treatment rescues neuromuscular junction transmission in glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) deficient mice

Congenital Myasthenic Syndromes (CMS) are a group of rare inherited neuromuscular disorders caused by genetic defects at the neuromuscular junction (NMJ). Patients with CMS experience...
award winners

Celebrating Lab Members’ Recent Research Awards

We are thrilled to celebrate Kelly Ho for receiving first place for her poster presentation at this year’s American Society for Pharmacology and Experimental Therapeutics...
New publication - RTD (2)

Meet The Lochmüller Lab’s Newest Members!

Our research team is growing! We are excited to introduce three new members who have recently joined the Lochmüller lab and several students who will...
McMillan smart study (1)

New Clinical Study Examines Safety and Efficacy of IV Onasemnogene Abeparvovec in Broad SMA Cohort

Pediatric neurologist Dr Hugh McMillan publishes clinical study examining the safety and efficacy of IV onasemnogene abeparvovec in the broadest cohort of SMA patients to...
Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...